Literature DB >> 8669933

Logarithmic quantitation model using serum ferritin to estimate iron overload in secondary haemochromatosis.

T Güngör1, E Rohrbach, E Solem, J P Kaltwasser, B Kornhuber.   

Abstract

Nineteen children and adolescents receiving repeated transfusions and subcutaneous desferrioxamine treatment were investigated in an attempt to quantitate iron overload non-invasively. Before patients were started on desferrioxamine individual relationships were correlated for 12 to 36 months between transfused iron, absorbed iron estimated gastrointestinally, and increasing serum ferritin concentrations. Patients with inflammation, increased liver enzymes, or haemolysis were excluded from analysis. The relationship between the variables could be described by a logarithmic regression curve (y = transfused iron [plus eventually gastrointestinally absorbed iron] = iron overload = a+b log [x = serum ferritin]) for each individual patient. All patients showed close correlation (R2) between x and y (median R2 of 0.909, 0.98, and 0.92 in thalassaemia, aplastic anaemia, and sickle cell anaemia patients, respectively). When started on desferrioxamine, current serum ferritin concentrations were used to derive the iron overload from each individual regression curve. The derived estimated iron overload ranged from 0.6 g to 31 g. Left ventricular dilatation was observed in three patients with beta thalassaemia and in one patient with aplastic anaemia with median iron overload of 20.7 (14.1-31.3) g and 24.0 g respectively. Hypothyroidism was found in four patients with beta thalassaemia and one patient with aplastic anaemia with iron overload between 14.7 (6.8 and 26.1) g and 15.1 g respectively. Human growth hormone deficiency was detected in three patients with beta thalassaemia with an iron overload of 4.2 (3.5-6.8) g; all three patients had excellent desferrioxamine compliance.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8669933      PMCID: PMC1511483          DOI: 10.1136/adc.74.4.323

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  15 in total

Review 1.  Diagnosis and clinical evaluation of iron overload.

Authors:  J P Kaltwasser; E Werner
Journal:  Baillieres Clin Haematol       Date:  1989-04

2.  Reappraisal of high-dose desferrioxamine therapy.

Authors:  G Schilirò; A Russo
Journal:  Acta Haematol       Date:  1986       Impact factor: 2.195

3.  Absorption of inorganic and food iron in children with heterozygous and homozygous beta-thalassemia.

Authors:  H C Heinrich; E E Gabbe; K H Oppitz; D H Whang; C Bender-Götze; K H Schäfer; W Schröter; A A Pfau
Journal:  Z Kinderheilkd       Date:  1973-08-09

4.  Correlation between computed tomographic values and liver iron content in thalassaemia major with iron overload.

Authors:  M T Houang; X Arozena; A Skalicka; E R Huehns; D G Shaw
Journal:  Lancet       Date:  1979-06-23       Impact factor: 79.321

5.  Serum ferritin in patients with iron overload and with acute and chronic liver diseases.

Authors:  J Prieto; M Barry; S Sherlock
Journal:  Gastroenterology       Date:  1975-03       Impact factor: 22.682

6.  Internal distribution of excess iron and sources of serum ferritin in patients with thalassemia.

Authors:  M Cazzola; C Borgna-Pignatti; P de Stefano; G Bergamaschi; I G Bongo; L Dezza; F Avato
Journal:  Scand J Haematol       Date:  1983-04

7.  Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis.

Authors:  M L Bassett; J W Halliday; L W Powell
Journal:  Hepatology       Date:  1986 Jan-Feb       Impact factor: 17.425

8.  An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload.

Authors:  G M Addison; M R Beamish; C N Hales; M Hodgkins; A Jacobs; P Llewellin
Journal:  J Clin Pathol       Date:  1972-04       Impact factor: 3.411

9.  Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions.

Authors:  N F Olivieri; J R Buncic; E Chew; T Gallant; R V Harrison; N Keenan; W Logan; D Mitchell; G Ricci; B Skarf
Journal:  N Engl J Med       Date:  1986-04-03       Impact factor: 91.245

Review 10.  Iron overload and iron chelation therapy in thalassaemia and sickle cell haemoglobinopathies.

Authors:  M J Pippard
Journal:  Acta Haematol       Date:  1987       Impact factor: 2.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.